Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorLENAIN, Remi
dc.contributor.authorBOUCQUEMONT, Julie
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorLEFFONDRE, Karen
IDREF: 183599128
dc.contributor.authorCOUCHOUD, Cecile
dc.contributor.authorLASSALLE, Mathilde
dc.contributor.authorHAZZAN, Marc
dc.contributor.authorFOUCHER, Yohann
dc.date.accessioned2021-06-29T09:45:10Z
dc.date.available2021-06-29T09:45:10Z
dc.date.issued2021-03-01
dc.identifier.issn1044-3983en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/79320
dc.description.abstractEnBACKGROUND: No study to our knowledge has examined the use of observational data to emulate a clinical trial whereby patients at the time of kidney transplant proposal are randomly assigned to an awaiting transplantation or transplantation group. The main methodologic issue is definition of the baseline for dialyzed patients assigned to awaiting transplantation, resulting in the inability to use common propensity score-based approaches. We aimed to use time-dependent propensity score to better appraise the benefit of transplantation. METHODS: We studied 23,231 patients included in the French registry and on a transplant waiting list from 2005 to 2016. The main outcome was time to death. By matching on time-dependent propensity score, we obtained 10,646 pairs of recipients (transplantation group) versus comparable patients remaining on dialysis (awaiting transplantation group). RESULTS: The baseline exposure, that is, pseudo-randomization, was matching time. Median follow-up time was 3.5 years. At 10 years' follow-up, the restricted mean survival time was 8.8 years [95% confidence interval (CI) = 8.7, 8.9] in the transplantation group versus 8.2 years (95% CI = 8.1, 8.3) in the awaiting transplantation group. The corresponding life expectancy gain was 6.8 months (95% CI = 5.5, 8.2), and this corresponded to one prevented death at 10 years for 13 transplantations. CONCLUSIONS: Our study has estimated the life expectancy gain due to kidney transplantation. It confirms transplantation as the best treatment for end-stage renal disease. Furthermore, we demonstrated that this simple method should also be considered for estimating marginal effects of time-dependent exposures.
dc.language.isoENen_US
dc.title.enClinical Trial Emulation by Matching Time-dependent Propensity Scores: The Example of Estimating Impact of Kidney Transplantation
dc.typeArticle de revueen_US
dc.identifier.doi10.1097/ede.0000000000001308en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed33284166en_US
bordeaux.journalEpidemiologyen_US
bordeaux.page220-229en_US
bordeaux.volume32en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue2en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamBIOSTAT_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03273513
hal.version1
hal.date.transferred2021-06-29T09:45:14Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Epidemiology&rft.date=2021-03-01&rft.volume=32&rft.issue=2&rft.spage=220-229&rft.epage=220-229&rft.eissn=1044-3983&rft.issn=1044-3983&rft.au=LENAIN,%20Remi&BOUCQUEMONT,%20Julie&LEFFONDRE,%20Karen&COUCHOUD,%20Cecile&LASSALLE,%20Mathilde&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée